eHealth (EHTH) Insider Beth Brooke Buys 61,041 Shares

Beth Brooke, an insider, purchased 61,041 shares of EHTH on June 18, 2026. This transaction was not part of a planned trading program. EHTH shares were trading at around $1.56 on Wednesday.

Other Institutional Activity in EHTH

BlackRock, Inc. reduced its holdings by 151,865 shares, leaving it with 2,691,787 shares valued at approximately $3.47 million, a 5.3% decrease. AQR Capital Management LLC significantly increased its stake by 1,635,374 shares, resulting in a total of 1,715,112 shares worth about $2.21 million, marking a 2050.9% increase. Vanguard Capital Management LLC opened a new position with 1,206,427 shares valued at roughly $1.56 million. Dimensional Fund Advisors LP trimmed its holdings by 133,660 shares to 828,200 shares, valued at $1.07 million, a 13.9% decrease.

eHealth, Inc. Stock Up 77.7%

EHTH traded at $1.56 on Wednesday. The company has a market cap of $1.56 billion and a beta of 1.2. The stock's 52-week range is between $1.50 and $3.00, with a 50-day moving average of $1.70 and a 200-day moving average of $2.10.

Insider Buying and Selling at eHealth, Inc.

Several insiders, including Beth Brooke, Todd Arden, John Hass, Francis Soistman Jr, Dale Wolf, and Erin Russell, each bought 61,041 shares of EHTH on June 18, 2026. These purchases were not made under a Rule 10b5-1 plan.

Analysts Set New Price Targets

On March 11, 2026, RBC Capital maintained a hold rating on EHTH with a price target of $3.00. Earlier, on February 26, 2026, Craig-Hallum downgraded the stock to a hold with a $2.00 target. The consensus among analysts is a hold rating, with a mean target price of $4.00 based on six opinions.

About EHTH

EHTH is a company focused on providing health insurance solutions. It operates an online marketplace where consumers can compare and purchase health insurance plans. The company is headquartered in Santa Clara, California.

Bottom Line

Beth Brooke's recent purchase of EHTH shares is part of a series of insider buys, reflecting potential confidence in the company's prospects. While institutional investors have shown mixed activity, with some increasing and others decreasing their positions, analysts maintain a cautious outlook with hold ratings. As always, 13F filings and insider transactions offer a historical view and may not represent current positions.